Alzinova
Alzinova publishes the Annual Report for 2023
MARKN.
Alzinova AB (publ) (FN STO: ALZ), a Swedish biopharma company developing disease-modifying treatments for Alzheimer’s, announces today that the Company’s Annual Report for 2023 has been published.
The Annual Report, which is attached in the press release, can also be downloaded from the company’s website, www.alzinova.com/investors/financial-reports/
Datum | 2024-05-07, kl 08:00 |
Källa | MFN |
![](https://static.allaaktier.se/ads/etoro-logo.png)
Copy Trading innebär inte investeringsråd. Värdet på dina investeringar kan gå upp eller ned. Ditt kapital löper risk.